Join
Live feed
·
PRReleasevia Quantisnow
Tempus AI Inc. logo

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

ByQuantisnow·Wall Street's wire, on your screen.
TEM· Tempus AI Inc.
Technology

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TEM (Tempus AI Inc.) and more on Quantisnow.